#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive familial intrahepatic cholestasis Vaginal cancer Activated PI3 kinase delta syndrome Canavan disease Angiosarcoma Marfan's syndrome Adrenogenital syndrome Hypertriglyceridaemia Haemophilia A without inhibitors Cataract Hereditary angioedema with C1 esterase inhibitor deficiency Pulmonary tuberculosis Ewing's sarcoma metastatic Malignant neoplasm of choroid Chronic lymphocytic leukaemia More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Trials in Disease Alexander disease – Diagnostics Ocular melanoma – Trials in Disease Prader-Willi syndrome Retinoblastoma – Treatment Hairy cell leukaemia recurrent – Basic Information Netherton’s syndrome – Treatment Inclusion body myositis – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Synovial sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fasudil Hydrochloride Ralinepag Ro7589655 Dactylis Glomerata IPN01195 Balcinrenone Norepinephrine Bimekizumab Phentermine Sumatriptan Succinate Caba-201 Copper (64Cu) Chloride TROFOLASTAT RNK001 LY3848575 ACETYLCARNITINE HYDROCHLORIDE Sodium Phosphate Dodecahydrate Venlafaxine Tuvusertib Roxadustat More therapies…

    Learn about Your Condition

    Nephropathy Cerebral palsy Castleman's disease Ependymoma malignant Colorectal adenocarcinoma Laryngeal cancer stage I Osteochondrodysplasia Macular degeneration Obsessive-compulsive disorder Corneal graft rejection HER2 positive breast cancer Glioblastoma multiforme Arthralgia Hypoxia Hand fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometrial cancer

  • Study of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Endometrial cancer
    Investigated Drugs:
    • Human Igg1K Monoclonal Antibody Against Tim-3
    • Pemigatinib
    • Retifanlimab
    Belgium France Greece Italy

  • Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    Belgium Czechia Denmark Finland Germany Hungary +7

  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Cervix carcinoma
    • Ovarian cancer
    Investigated Drugs:
    • Anhydrous Caffeine
    • Paracetamol Dc
    • Paracetamol Ph. Eur.
    Belgium France Poland Spain

  • Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Loperamide
    Austria Czechia Denmark Estonia Finland France +9

  • Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Gen1046
    • Pembrolizumab
    Belgium Denmark Italy Poland Spain

  • Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark Finland France +7
Previous Page
1 … 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!